Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort | Vanlerberghe, Julia
/5

0 avis

Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort

Archive ouverte : Article de revue

Vanlerberghe, Julia | Dezoteux, Frédéric | Martin, Claire | Jachiet, Marie | Soria, Angèle | Tétart, Florence | Modeste-Duval, Anne-Bénédicte | Bursztejn, Anne-Claire | Misery, Laurent | Aubin, François | Lasek, Audrey | Leleu, Camille | Du-Thanh, Aurélie | Pasteur, Justine | Pralong, Pauline | Nosbaum, Audrey | Droitcourt, Catherine | Viguier, Manuelle | Tauber, Marie | Seneschal, Julien | Barbarot, Sébastien | Staumont-Sallé, Delphine

Edité par HAL CCSD ; Elsevier

International audience

Consulter en ligne

Suggestions

Du même auteur

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort | Faiz, Sarah

Effectiveness and safety of dupilumab for the treatment of atopic dermatiti...

Archive ouverte: Article de revue

Faiz, Sarah | 2019-07

International audience. BackgroundDupilumab is the first biologic available to treat atopic dermatitis (AD). Its effectiveness and safety were demonstrated in clinical trials.ObjectiveWe sought to assess the effecti...

Efficacité et tolérance du dupilumab dans le traitement de la dermatite atopique de l’enfant de moins de 12 ans en vie courante : cohorte rétrospective multicentrique française | Lasek, Audrey

Efficacité et tolérance du dupilumab dans le traitement de la dermatite ato...

Archive ouverte: Article de revue

Lasek, Audrey | 2021-12

International audience

Evaluation of children with Psoriasis from the BiPe Cohort: are patients using biotherapies in real life eligible for phase III clinical studies? | Phan, Céline

Evaluation of children with Psoriasis from the BiPe Cohort: are patients us...

Archive ouverte: Article de revue

Phan, Céline | 2019

International audience. Background Phase III clinical trials of biotherapies for childhood psoriasis are designed for a selected population, which can differ from real-life patients. Objective Our objective was to a...

Chargement des enrichissements...